• E-mailRolf.Bjerkvig@uib.no
  • Phone+47 55 58 63 52+47 951 18 268
  • Visitor Address
    Jonas Lies vei 91
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen

Rolf Bjerkvig (f. 1953) is Professor for cell biology and has since the ealy 80s worked in experimental cancer biology.

Dr Bjerkvig receives major grants from the Norwegian Research Council, The Norwegian Cancer Society and the European Commission. He is on the editorial board on several international journals and is sitting in several national as well as international funding committees for cancer research in Europe. He has published more than 200 articles in scientific literature and has received a number of research prizes for his work. In 2015, Bjerkvig was awarded the King Olav V Research Prize in Cancer Research.

OD1ANA - Anatomy



FARM260 - Molecular cell biology

BMED330 - intercellular communication

BMED331 - tumor biology

  • Show author(s) (2022). Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors. Neuro-Oncology. 1074-1087.
  • Show author(s) (2022). Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis. EMBO Molecular Medicine. 1-20.
  • Show author(s) (2021). Williams Syndrome Transcription Factor (WSTF) in Brain Tumor Drug Resistance.
  • Show author(s) (2021). TGF-β promotes microtube formation in glioblastoma through thrombospondin 1. Neuro-Oncology. 541-553.
  • Show author(s) (2021). Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors. STAR Protocols.
  • Show author(s) (2021). Novel thioridazine derivates: antiproliferative and apoptosis-inducing activity on glioblastoma cells in vitro get access arrow. Neuro-Oncology. vi170-vi170.
  • Show author(s) (2021). Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1. Acta Neuropathologica. 179-189.
  • Show author(s) (2021). Cystathionine-γ-lyase drives antioxidant defense in cysteine-restricted IDH1-mutant astrocytomas. Neuro-Oncology Advances (NOA).
  • Show author(s) (2021). Current landscape and future perspectives in preclinical MR and PET imaging of brain metastasis. Neuro-Oncology Advances (NOA). 14 pages.
  • Show author(s) (2021). A subset of PARP inhibitors induces lethal telomere fusion in ALT-dependent tumor cells. Science Translational Medicine.

More information in national current research information system (CRIStin)

1987: Dr. philos. The Gade Institute of Pathology, University of Bergen
1981: M.Sc. Immunology, University of San Francisco, 1981.

Fields of competence